KRAS-533

KRAS-533 is a potent agonist of KRAS that binds to the GTP/GDP-binding pocket and prevents the hydrolysis of GTP, leading to accumulation of active GTP-bound KRAS. This triggers both apoptotic and autophagic cell death pathways in cancer cells, leading to potent suppression of mutant KRAS lung cancer in vitro and in animal models.

Price Not Available 100mg KRAS-533 Supplier Page
Catalog Number E5910
Molecular Formula C19H30N5O10P.C4H4O4
CAS# 10161-87-2
Inchi InChI=1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6 )(H,7,8)/b;2-1+/t14-;/m1./s1
Inchi Key VCMJCVGFSROFHV-WZGZYPNHSA-N
SMILES CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O
Size 100mg
Supplier Page http://www.selleckchem.com/products/kras-533.html
Additional Information https://file.selleck.cn/downloads/struct/E5910-KRAS-533-chemical-structure.png